Hi, what are you looking for?
Jewish Business News
Search results for "Copaxone"
Court
– The US Supreme Court has in effect allowed generic versions of the MS drug from next month. – Please help us out :...
Court
– – The US Supreme Court has agreed to hear an appeal by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) over the expiry of its patents for...
StartUps
– Synthon says its Phase III clinical trial of glatiramer acetate found an equivalent efficacy and safety profile to Copaxone. – – Dutch drug...
Business
– Teva earned lower profits on flat revenue for 2013, but beat the analysts’ consensus. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported...
Business
– – U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) new dose of COPAXONE drug application (sNDA) for three-times-a-week 40mg/mL....
Court
– Teva expects the Supreme Court to hear the case in April, a month before the Copaxone patents expire. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
Business
– In its 2014 guidance Teva provides a pessimistic scenario with generic Copaxone competition, and an optimistic one with Copaxone exclusivity. – CEO Eyal...
Business
– Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company Limited ((TSE: 4502) today announced the signing earlier this year of an agreement in...
Court
– The companies have agreed to settle pending patent litigation involving Copaxone in the UK, Netherlands and France. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
Court
– The court dismissed a motion to put a lower court ruling on hold while it decides Teva’s appeal against earlier invalidation of Copaxone’s...